JP2016501260A5 - - Google Patents

Download PDF

Info

Publication number
JP2016501260A5
JP2016501260A5 JP2015546418A JP2015546418A JP2016501260A5 JP 2016501260 A5 JP2016501260 A5 JP 2016501260A5 JP 2015546418 A JP2015546418 A JP 2015546418A JP 2015546418 A JP2015546418 A JP 2015546418A JP 2016501260 A5 JP2016501260 A5 JP 2016501260A5
Authority
JP
Japan
Prior art keywords
mal
ppi
iii
dendrimer
maltotriose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015546418A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016501260A (ja
Filing date
Publication date
Priority claimed from PL401934A external-priority patent/PL234887B1/pl
Application filed filed Critical
Publication of JP2016501260A publication Critical patent/JP2016501260A/ja
Publication of JP2016501260A5 publication Critical patent/JP2016501260A5/ja
Pending legal-status Critical Current

Links

JP2015546418A 2012-12-06 2013-12-03 マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−DS−Mal−IIIの使用 Pending JP2016501260A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PLP.401934 2012-12-06
PL401934A PL234887B1 (pl) 2012-12-06 2012-12-06 Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-DS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej
PCT/PL2013/000154 WO2014088434A1 (en) 2012-12-06 2013-12-03 Application of maltotriose-coated 4th generation polypropyleneimine dendrimer ppi-g4-ds-mal-iii

Publications (2)

Publication Number Publication Date
JP2016501260A JP2016501260A (ja) 2016-01-18
JP2016501260A5 true JP2016501260A5 (cg-RX-API-DMAC10.html) 2017-01-19

Family

ID=49955471

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015546418A Pending JP2016501260A (ja) 2012-12-06 2013-12-03 マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−DS−Mal−IIIの使用

Country Status (9)

Country Link
US (1) US20150320692A1 (cg-RX-API-DMAC10.html)
EP (1) EP2928478A1 (cg-RX-API-DMAC10.html)
JP (1) JP2016501260A (cg-RX-API-DMAC10.html)
KR (1) KR20150099539A (cg-RX-API-DMAC10.html)
AU (1) AU2013356792A1 (cg-RX-API-DMAC10.html)
CA (1) CA2896673A1 (cg-RX-API-DMAC10.html)
IL (1) IL239143A0 (cg-RX-API-DMAC10.html)
PL (1) PL234887B1 (cg-RX-API-DMAC10.html)
WO (1) WO2014088434A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL234888B1 (pl) * 2012-12-06 2020-04-30 Univ Lodzki Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-OS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090208580A1 (en) * 2005-09-19 2009-08-20 Regents Of The University Of Michigan Functionalized dendrimer-encapsulated and dendrimer-stabilized nanoparticles
US20110177602A1 (en) * 2007-06-27 2011-07-21 Endress + Hauser Conducts Gesellschaft furMess-und Regeltechnik mbH +Co. KG Composite Structure
PL234888B1 (pl) * 2012-12-06 2020-04-30 Univ Lodzki Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-OS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej

Similar Documents

Publication Publication Date Title
JP2011173928A5 (cg-RX-API-DMAC10.html)
JP2013155188A5 (cg-RX-API-DMAC10.html)
JP2013541583A5 (cg-RX-API-DMAC10.html)
JP2016501865A5 (cg-RX-API-DMAC10.html)
FI3435996T3 (fi) Elafibranori käytettäväksi primaarisen biliaarisen kolangiitin hoidossa
JP2017512194A5 (cg-RX-API-DMAC10.html)
ME02395B (me) Kombinovana terapija sa antitumorskim alkaloidima
JP2017507142A5 (cg-RX-API-DMAC10.html)
JP2013527232A5 (cg-RX-API-DMAC10.html)
JP2019524865A5 (cg-RX-API-DMAC10.html)
JP2014530220A5 (cg-RX-API-DMAC10.html)
JP2015517983A5 (cg-RX-API-DMAC10.html)
NI201800066A (es) Derivados de 2-fenil-3-(piperazinometil)imidazo[1,2-a]piridina como bloqueadores de los canales task-1 y task-2 para el tratamiento de trastornos respiratorios relacionados con el sueño.
EA201492010A1 (ru) Применение высокой дозы лахинимода для лечения рассеянного склероза
JP2018522028A5 (cg-RX-API-DMAC10.html)
JP2018537507A5 (cg-RX-API-DMAC10.html)
JP2019531293A5 (cg-RX-API-DMAC10.html)
JP2011190199A5 (cg-RX-API-DMAC10.html)
JP2016530291A5 (cg-RX-API-DMAC10.html)
JP2016515550A5 (cg-RX-API-DMAC10.html)
JP2010500284A5 (cg-RX-API-DMAC10.html)
JP2014504636A5 (cg-RX-API-DMAC10.html)
JP2014148552A5 (cg-RX-API-DMAC10.html)
JP2016505050A5 (cg-RX-API-DMAC10.html)
JP2016501261A5 (cg-RX-API-DMAC10.html)